Skip to the main content.
Request a Quote

At Fluxion, we’re passionate about delivering cell-based solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.

Fluxion Blog

Ready to learn something new? You've come to the right place. 


5 min read

Liquid Biopsy Sensitivity and Accuracy: Are We There Yet?

A newly published paper coauthored by researchers at Fluxion and Hospices Civils de Lyon Cancer Institute tested the sensitivity and accuracy of...

Read More
Blood in test tubes

2 min read

Liquid Biopsy Frequently Asked Questions (FAQ)

What is a liquid biopsy? A liquid biopsy is a blood test that analyzes cancer cells (CTCs) or fragments of cancer DNA (termed cfDNA or ctDNA)...

Read More